CD274 and neoplasm: Programmed cell death ligand 1 (PD-L1), expressed on both tumour cells and lymphocytes, and PD-1 receptor expressed on lymphocytes, both constitute so-called immune checkpoints, which inhibit an immune response against the tumour [4].